advertisement
Journal of Ocular Pharmacology and Therapeutics 41
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics73475 The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Cairns EA
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 582-590
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Lin CW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73324 Aquaporins: Novel Targets for Age-Related Ocular Disorders
Patil R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 177-187
72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Antoun J
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Stahl E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
73131 Pirfenidone Induces G1 Arrest in Human Tenon's Fibroblasts In Vitro Involving AKT and MAPK Signaling Pathways
Guo X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 366-374
73324 Aquaporins: Novel Targets for Age-Related Ocular Disorders
Wang H
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 177-187
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Bremond-Gignac D
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Sherman B
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73131 Pirfenidone Induces G1 Arrest in Human Tenon's Fibroblasts In Vitro Involving AKT and MAPK Signaling Pathways
Yang Y
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 366-374
73475 The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Szczesniak AM
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 582-590
72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Willermain F
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Moore LA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73131 Pirfenidone Induces G1 Arrest in Human Tenon's Fibroblasts In Vitro Involving AKT and MAPK Signaling Pathways
Liu L
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 366-374
73475 The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Straiker AJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 582-590
73324 Aquaporins: Novel Targets for Age-Related Ocular Disorders
Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 177-187
72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Makhoul D
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Landry T
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Laethem CL
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73131 Pirfenidone Induces G1 Arrest in Human Tenon's Fibroblasts In Vitro Involving AKT and MAPK Signaling Pathways
Liu X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 366-374
72888 Topical Ganciclovir in Cytomegalovirus Anterior Uveitis
Motulsky E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 313-318
73475 The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Kulkarni PM
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 582-590
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Curtis M
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
73324 Aquaporins: Novel Targets for Age-Related Ocular Disorders
Mitra A
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 177-187
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Gedif K
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
